XML 31 R7.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidated Statement of Cash Flows (USD $)
6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS:    
NET INCREASE (DECREASE) IN SHAREHOLDERS' EQUITY RESULTING FROM OPERATIONS $ 9,785,590 $ 11,326,588
Reconciliation of the net increase (decrease) in shareholders' equity resulting from operations to net cash provided by (used in) operating activities:    
Change in net unrealized (gain) loss on investments and financial derivatives 20,574,111 20,741,646
Net realized (gain) loss on investments and financial derivatives (7,687,766) (17,928,195)
Amortization of premiums and accretion of discounts (net) (5,249,519) (3,197,557)
Purchase of investments (1,611,306,332) (1,197,262,915)
Proceeds from disposition of investments 1,611,907,045 1,032,332,961
Proceeds from principal payments of investments 51,972,572 66,373,369
Proceeds from investments sold short 939,340,941 721,847,421
Repurchase of investments sold short (1,193,782,745) (519,186,218)
Payments made to open financial derivatives (94,317,675) (167,814,104)
Proceeds received to close financial derivatives 170,997,519 130,603,829
Proceeds received to open financial derivatives 13,087,106 39,865,010
Payments made to close financial derivatives (20,735,291) (29,218,557)
Shares issued in connection with incentive fee payment 203,369 275,689
Share-based LTIP expense 75,435 1,500,200
(Increase) decrease in assets:    
(Increase) decrease in repurchase agreements 3,246,250  
(Increase) decrease in receivable for securities sold 245,578,409 (271,452,941)
(Increase) decrease in deposits with dealers held as collateral (3,050) (7,172,282)
(Increase) decrease in interest and principal receivable (1,408,928) 4,927,232
(Increase) decrease in other assets (333,255) (534,005)
Increase (decrease) in liabilities:    
Increase (decrease) in due to brokers - margin accounts (49,903,794) 13,257,911
Increase (decrease) in payable for securities purchased (66,079,890) 329,572,335
Increase (decrease) in accounts payable and accrued expenses 348,429 963,979
Increase (decrease) in incentive fee payable (1,421,500) (2,274,530)
Increase (decrease) in interest and dividends payable 16,194 (100,676)
Increase (decrease) in base management fee payable (76,184) (29,053)
Net cash provided by (used in) operating activities 14,827,041 157,417,137
Cash flows provided by (used in) financing activities:    
Offering costs paid (438,762) (594,362)
Dividends paid (28,882,514) (18,546,036)
Reverse repurchase agreements, net of repayments 24,140,740 (131,808,301)
Net cash provided by (used in) financing activities (5,180,536) (150,948,699)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 9,646,505 6,468,438
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 35,790,818 102,863,164
CASH AND CASH EQUIVALENTS, END OF PERIOD 45,437,323 109,331,602
Supplemental disclosure of cash flow information:    
Interest paid 3,129,671 1,698,889
Shares issued in connection with incentive fee payment (non-cash) 203,369 275,689
Share-based LTIP awards (non-cash) 75,435 1,500,200
Aggregate TBA trade activity (buys + sells) (non-cash) $ 11,055,413,893 $ 6,089,897,901